Teva Stock Is Getting Destroyed. Is Now The Time To Buy?

Teva (ADR: TEVA) has been a darling for investors in the generic drug sector. Even as recently as last year, investors were eager to see the growth of the company and along with it, the stock price. But then second quarter earnings were reported and Teva stock price hit the fan as they say.

Teva stock price has since cratered 45% since earnings were released and there is no sign of the price coming back. So should investors, particularly value investors take a look at Teva?

In this post, we will look at Teva stock and see whether or not there is a value play here or if you are better served putting your investing dollars elsewhere.

No comments:

Post a Comment

Week's Most Significant Insider Trades: January 22 - 26, 2018

Disposals: Cardinal Health Inc (NYSE:CAH) CEO Michael C. Kaufmann sold 18,586 shares of the business’s stock in a transaction tha...